Header cover image
  • Investing Ideas
  • Finnish Pharmaceuticals & Biotech Large Cap High Growth Potential

Finnish Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

Orion Oyj

Market Cap: €11.4b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€80.80

7D

3.1%

1Y

17.0%